The University of Chicago Header Logo

Connection

Jeremy Segal to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Jeremy Segal has written about Dose-Response Relationship, Drug.
Jeremy Segal
Connection Strength
0.030
Dose-Response Relationship, Drug
  1. Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clin Cancer Res. 2019 02 15; 25(4):1174-1184.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.